Clinical trial

The Efficacy and Safety of Udenafil in Patients With Erectile Dysfunction After Bilateral Nerve-sparing Radical Prostatectomy

NCT03142542

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention ZYDENA TAB.75mg(Udenafil 75mg) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Oral Tablet Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

The Efficacy and Safety of Udenafil in Patients With Erectile Dysfunction After Bilateral Nerve-sparing Radical Prostatectomy

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2017-05-01

PhasePHASE4

Conditions

Prostate Cancer With Radical Prostatectomyunresolved

Interventions

ZYDENA TAB.75mg(Udenafil 75mg)DRUG

Placebo Oral TabletDRUG

Sponsors & collaborators

Samsung Medical Centerlead sponsor

Dong-A ST Co., Ltd.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03142542 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.